Clinical trial
IDBV: Inflammation Digital Biomarker Validation Study
NCT07594054 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IDBV: Inflammation Digital Biomarker Validation Study
- Lead sponsor
- University of Oxford
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- December 31, 2027
- Enrollment
- 3,458 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
psoriasis (pso), psoriatic arthritis